Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

English (EN)·Polski (PL)·Ukraiński (UK)
Przejdź do strony domowej biblioteki Uniwersytet Ekonomiczny we Wrocławiu Link otwiera się w nowym oknie Logo biblioteki Prolib Integro - strona głównaUniwersytet Ekonomiczny we Wrocławiu

Wyszukujesz frazę ""Porreca F"" wg kryterium: Autor

  Lista filtrów
Wyrównaj
Wyświetlanie 1-20 z 53
Tytuł:
Breaking barriers in migraine care: Advancing gender medicine to bridge the gap for men.
Autorzy:
Sacco S; Department of Biotechnological and Applied Clinical Sciences, University of L'Aquila, L'Aquila, Italy.
Porreca F; Department of Pharmacology, University of Arizona, Tucson, USA.; Mayo Clinic Arizona, Phoenix, Arizona, USA.
Pokaż więcej
Źródło:
Cephalalgia : an international journal of headache [Cephalalgia] 2024 Mar; Vol. 44 (3), pp. 3331024241238157.
Typ publikacji:
Editorial
MeSH Terms:
Migraine Disorders*/therapy
Male ; Humans
Opinia redakcyjna
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Evaluation of outcomes of calcitonin gene-related peptide (CGRP)-targeting therapies for acute and preventive migraine treatment based on patient sex.
Autorzy:
Porreca F; Department of Pharmacology, University of Arizona, Tucson, USA.; Mayo Clinic Arizona, Phoenix, USA.
Navratilova E; Department of Pharmacology, University of Arizona, Tucson, USA.; Mayo Clinic Arizona, Phoenix, USA.
Hirman J; Pacific Northwest Statistical Consulting, Woodinville, USA.
van den Brink AM; Department of Internal Medicine, Division of Pharmacology, Vascular Medicine and Metabolic Diseases, Erasmus MC University Medical Center Rotterdam, The Netherlands.
Lipton RB; Departments of Neurology, Psychiatry and Behavioral Science, and Epidemiology and Population Health, Albert Einstein College of Medicine, Bronx, NY, USA.
Dodick DW; Mayo Clinic Arizona, Phoenix, USA.; Atria Academy of Science and Medicine, New York, USA.
Pokaż więcej
Źródło:
Cephalalgia : an international journal of headache [Cephalalgia] 2024 Mar; Vol. 44 (3), pp. 3331024241238153.
Typ publikacji:
Journal Article; Review
MeSH Terms:
Calcitonin Gene-Related Peptide*
Migraine Disorders*/drug therapy
Piperidines*
Pyridines*
Pyrroles*
Spiro Compounds*
Female ; Humans ; Male ; Calcitonin Gene-Related Peptide Receptor Antagonists/therapeutic use ; Antibodies, Monoclonal/therapeutic use ; Pain/drug therapy
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Identification of brain areas in mice with peak neural activity across the acute and persistent phases of post-traumatic headache.
Autorzy:
Rudolph M; Department of Pharmacology, College of Medicine, University of Arizona, Tucson, Arizona, USA.; Department of Basic Medical Sciences, College of Medicine, University of Arizona, Phoenix, Arizona, USA.
Kopruszinski C; Department of Pharmacology, College of Medicine, University of Arizona, Tucson, Arizona, USA.
Wu C; Department of Pharmacology, College of Medicine, University of Arizona, Tucson, Arizona, USA.; Department of Basic Medical Sciences, College of Medicine, University of Arizona, Phoenix, Arizona, USA.
Navratilova E; Department of Pharmacology, College of Medicine, University of Arizona, Tucson, Arizona, USA.; Department of Neurology, Mayo Clinic, Phoenix, USA.
Schwedt TJ; Department of Neurology, Mayo Clinic, Phoenix, USA.
Dodick DW; Mayo Clinic College of Medicine, Scottsdale, Arizona, USA.; Atria Academy of Science and Medicine, New York City, New York, USA.
Porreca F; Department of Pharmacology, College of Medicine, University of Arizona, Tucson, Arizona, USA.
Anderson T; Department of Pharmacology, College of Medicine, University of Arizona, Tucson, Arizona, USA.; Department of Basic Medical Sciences, College of Medicine, University of Arizona, Phoenix, Arizona, USA.
Pokaż więcej
Źródło:
Cephalalgia : an international journal of headache [Cephalalgia] 2023 Nov; Vol. 43 (11), pp. 3331024231217469.
Typ publikacji:
Journal Article
MeSH Terms:
Post-Traumatic Headache*/etiology
Brain Concussion*
Humans ; Mice ; Male ; Female ; Animals ; Hyperalgesia/metabolism ; Mice, Inbred C57BL ; Headache/metabolism ; Brain ; Pain
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Preclinical assessment of onabotulinumtoxinA for the treatment of mild traumatic brain injury-related acute and persistent post-traumatic headache.
Autorzy:
Navratilova E; Department of Pharmacology, Arizona Health Sciences Center, University of Arizona, Tucson, AZ, USA.
Oyarzo J; Mayo Clinic, Scottsdale, AZ, USA.
Anderson T; Department of Basic Medical Sciences, University of Arizona College of Medicine, Phoenix, AZ, USA.
Broide RS; Allergan Aesthetics, an AbbVie Company, USA.
Subramaniam SR; Allergan Aesthetics, an AbbVie Company, USA.
Vazquez-Cintron EJ; Allergan Aesthetics, an AbbVie Company, USA.
Brin MF; Allergan Aesthetics, an AbbVie Company, USA.; Department of Neurology, University of California, Irvine, CA, USA.
Schwedt TJ; Mayo Clinic, Scottsdale, AZ, USA.
Dodick DW; Mayo Clinic, Scottsdale, AZ, USA.
Porreca F; Department of Pharmacology, Arizona Health Sciences Center, University of Arizona, Tucson, AZ, USA.; Mayo Clinic, Scottsdale, AZ, USA.
Pokaż więcej
Źródło:
Cephalalgia : an international journal of headache [Cephalalgia] 2022 Oct; Vol. 42 (11-12), pp. 1194-1206. Date of Electronic Publication: 2022 May 11.
Typ publikacji:
Journal Article
MeSH Terms:
Botulinum Toxins, Type A*/therapeutic use
Brain Concussion*/drug therapy
Post-Traumatic Headache*/drug therapy
Post-Traumatic Headache*/etiology
Tension-Type Headache*/drug therapy
Animals ; Headache/drug therapy ; Hyperalgesia/drug therapy ; Hyperalgesia/etiology ; Mice ; Pain/drug therapy
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Biochemical and Neuropathological Findings in a Creutzfeldt-Jakob Disease Patient with the Rare Val180Ile-129Val Haplotype in the Prion Protein Gene.
Autorzy:
Zanusso G; Department of Neurosciences, Biomedicine and Movement Sciences, University of Verona, 37134 Verona, Italy.
Colaizzo E; Department of Neuroscience, Istituto Superiore di Sanità, 00161 Rome, Italy.
Poleggi A; Department of Neuroscience, Istituto Superiore di Sanità, 00161 Rome, Italy.
Masullo C; Department of Neuroscience, Catholic University of the Sacred Heart, 00168 Rome, Italy.
Romeo R; Unit of Otolaryngology, Clinica Nuova Itor Rome, 00158 Rome, Italy.
Ferrari S; Department of Neurosciences, Biomedicine and Movement Sciences, University of Verona, 37134 Verona, Italy.
Bongianni M; Department of Neurosciences, Biomedicine and Movement Sciences, University of Verona, 37134 Verona, Italy.
Fiorini M; Department of Neurosciences, Biomedicine and Movement Sciences, University of Verona, 37134 Verona, Italy.
Tiple D; Department of Neuroscience, Istituto Superiore di Sanità, 00161 Rome, Italy.
Vaianella L; Department of Neuroscience, Istituto Superiore di Sanità, 00161 Rome, Italy.
Sbriccoli M; Department of Neuroscience, Istituto Superiore di Sanità, 00161 Rome, Italy.
Porreca F; Department of Neuroscience, Istituto Superiore di Sanità, 00161 Rome, Italy.
Equestre M; Department of Neuroscience, Istituto Superiore di Sanità, 00161 Rome, Italy.
Pocchiari M; Department of Neuroscience, Istituto Superiore di Sanità, 00161 Rome, Italy.
Cardone F; Department of Neuroscience, Istituto Superiore di Sanità, 00161 Rome, Italy.
Ladogana A; Department of Neuroscience, Istituto Superiore di Sanità, 00161 Rome, Italy.
Pokaż więcej
Źródło:
International journal of molecular sciences [Int J Mol Sci] 2022 Sep 06; Vol. 23 (18). Date of Electronic Publication: 2022 Sep 06.
Typ publikacji:
Journal Article
MeSH Terms:
Creutzfeldt-Jakob Syndrome*/genetics
Creutzfeldt-Jakob Syndrome*/pathology
Prions*/metabolism
Brain/metabolism ; Endopeptidase K/metabolism ; Haplotypes ; Humans ; Prion Proteins/genetics ; Prion Proteins/metabolism
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
A prolactin-dependent sexually dimorphic mechanism of migraine chronification.
Autorzy:
Ikegami D; Department of Pharmacology, College of Medicine, University of Arizona, Tucson, AZ 85724.
Navratilova E; Department of Pharmacology, College of Medicine, University of Arizona, Tucson, AZ 85724.; Departments of Neurology and Neuroscience, Mayo Clinic, Scottsdale, AZ 85259.
Yue X; Department of Pharmacology, College of Medicine, University of Arizona, Tucson, AZ 85724.
Moutal A; Department of Pharmacology, College of Medicine, University of Arizona, Tucson, AZ 85724.
Kopruszinski CM; Department of Pharmacology, College of Medicine, University of Arizona, Tucson, AZ 85724.
Khanna R; Department of Pharmacology, College of Medicine, University of Arizona, Tucson, AZ 85724.
Patwardhan A; Department of Pharmacology, College of Medicine, University of Arizona, Tucson, AZ 85724.
Dodick DW; Departments of Neurology and Neuroscience, Mayo Clinic, Scottsdale, AZ 85259.
Porreca F; Department of Pharmacology, College of Medicine, University of Arizona, Tucson, AZ 85724.; Departments of Neurology and Neuroscience, Mayo Clinic, Scottsdale, AZ 85259.
Pokaż więcej
Źródło:
Cephalalgia : an international journal of headache [Cephalalgia] 2022 Mar; Vol. 42 (3), pp. 197-208. Date of Electronic Publication: 2021 Sep 12.
Typ publikacji:
Journal Article
MeSH Terms:
Headache Disorders, Secondary*
Migraine Disorders*/chemically induced
Migraine Disorders*/metabolism
Animals ; Female ; Humans ; Hyperalgesia/chemically induced ; Male ; Mice ; Prolactin/adverse effects ; Prolactin/metabolism ; Sumatriptan/pharmacology
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Relief of neuropathic pain by cell-specific manipulation of nucleus accumbens dopamine D1- and D2-receptor-expressing neurons.
Autorzy:
Sato D; Department of Pharmacology, Hoshi University School of Pharmacy and Pharmaceutical Sciences, 2-4-41 Ebara, Shinagawa-ku, 142-8501, Tokyo, Japan.; Division of Cancer Pathophysiology, National Cancer Center Research Institute (NCCRI), 5-1-1 Tsukiji, Chuo-ku, 104-0045, Tokyo, Japan.
Narita M; Division of Cancer Pathophysiology, National Cancer Center Research Institute (NCCRI), 5-1-1 Tsukiji, Chuo-ku, 104-0045, Tokyo, Japan.; Department of Molecular and Cellular Medicine, Institute of Medical science, Tokyo Medical University, 6-7-1 Nishishinjuku, Shinjuku-ku, 160-0023, Tokyo, Japan.
Hamada Y; Department of Pharmacology, Hoshi University School of Pharmacy and Pharmaceutical Sciences, 2-4-41 Ebara, Shinagawa-ku, 142-8501, Tokyo, Japan.; Division of Cancer Pathophysiology, National Cancer Center Research Institute (NCCRI), 5-1-1 Tsukiji, Chuo-ku, 104-0045, Tokyo, Japan.
Mori T; Department of Pharmacology, Hoshi University School of Pharmacy and Pharmaceutical Sciences, 2-4-41 Ebara, Shinagawa-ku, 142-8501, Tokyo, Japan.
Tanaka K; Department of Pharmacology, Hoshi University School of Pharmacy and Pharmaceutical Sciences, 2-4-41 Ebara, Shinagawa-ku, 142-8501, Tokyo, Japan.; Division of Cancer Pathophysiology, National Cancer Center Research Institute (NCCRI), 5-1-1 Tsukiji, Chuo-ku, 104-0045, Tokyo, Japan.
Tamura H; Institute for Advanced Life Sciences, Hoshi University School of Pharmacy and Pharmaceutical Sciences, 2-4-41 Ebara, Shinagawa-ku, 142-0063, Tokyo, Japan.; Laboratory of Biofunctional Science, Hoshi University School of Pharmacy and Pharmaceutical Sciences, 2-4-41 Ebara, Shinagawa-ku, 142-0063, Tokyo, Japan.
Yamanaka A; Department of Neuroscience II, Research Institute of Environmental Medicine, Nagoya University, Furo-cho, Chikusa-ku, 464-8601, Nagoya, Japan.
Matsui R; Department of Biological Sciences, Graduate school of Medicine, Kyoto University, Yoshida, Sakyo-ku, 606-8501, Kyoto, Japan.
Watanabe D; Department of Biological Sciences, Graduate school of Medicine, Kyoto University, Yoshida, Sakyo-ku, 606-8501, Kyoto, Japan.
Suda Y; Department of Pharmacology, Hoshi University School of Pharmacy and Pharmaceutical Sciences, 2-4-41 Ebara, Shinagawa-ku, 142-8501, Tokyo, Japan.; Division of Cancer Pathophysiology, National Cancer Center Research Institute (NCCRI), 5-1-1 Tsukiji, Chuo-ku, 104-0045, Tokyo, Japan.
Senba E; Department of Physical Therapy, Osaka Yukioka College of Health Science, 1-1-41 Sojiji, Ibaraki-City, 567-0801, Osaka, Japan.; Department of Rehabilitation Medicine, Wakayama Medical University, 811-1 Kimiidera,Wakayama City, 641-8509, Wakayama, Japan.
Watanabe M; Department of Pharmacology, Arizona Health Sciences Center, University of Arizona, 1501 N. Campbell Avenue, 85724, Tucson, AZ, USA.
Navratilova E; Department of Pharmacology, Arizona Health Sciences Center, University of Arizona, 1501 N. Campbell Avenue, 85724, Tucson, AZ, USA.
Porreca F; Department of Pharmacology, Arizona Health Sciences Center, University of Arizona, 1501 N. Campbell Avenue, 85724, Tucson, AZ, USA.
Kuzumaki N; Department of Pharmacology, Hoshi University School of Pharmacy and Pharmaceutical Sciences, 2-4-41 Ebara, Shinagawa-ku, 142-8501, Tokyo, Japan. .; Division of Cancer Pathophysiology, National Cancer Center Research Institute (NCCRI), 5-1-1 Tsukiji, Chuo-ku, 104-0045, Tokyo, Japan. .
Narita M; Department of Pharmacology, Hoshi University School of Pharmacy and Pharmaceutical Sciences, 2-4-41 Ebara, Shinagawa-ku, 142-8501, Tokyo, Japan. .; Division of Cancer Pathophysiology, National Cancer Center Research Institute (NCCRI), 5-1-1 Tsukiji, Chuo-ku, 104-0045, Tokyo, Japan. .
Pokaż więcej
Źródło:
Molecular brain [Mol Brain] 2022 Jan 06; Vol. 15 (1), pp. 10. Date of Electronic Publication: 2022 Jan 06.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Neuralgia*
Nucleus Accumbens*
Animals ; Dopamine ; Dopaminergic Neurons/metabolism ; Receptors, Dopamine D2/metabolism
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
CGRP monoclonal antibody prevents the loss of diffuse noxious inhibitory controls (DNIC) in a mouse model of post-traumatic headache.
Autorzy:
Kopruszinski CM; Department of Pharmacology, College of Medicine, University of Arizona, Tucson, Arizona, USA.
Turnes JM; Department of Pharmacology, Federal University of Parana, Curitiba, Parana, Brazil.
Swiokla J; Department of Pharmacology, College of Medicine, University of Arizona, Tucson, Arizona, USA.
Weinstein TJ; Department of Pharmacology, College of Medicine, University of Arizona, Tucson, Arizona, USA.
Schwedt TJ; Department of Neurology, Mayo Clinic, Phoenix, AZ, USA.
Dodick DW; Department of Neurology, Mayo Clinic, Phoenix, AZ, USA.
Anderson T; Department of Biomedical Sciences, College of Medicine, University of Arizona, Phoenix, AZ, USA.
Navratilova E; Department of Pharmacology, College of Medicine, University of Arizona, Tucson, Arizona, USA.
Porreca F; Department of Pharmacology, College of Medicine, University of Arizona, Tucson, Arizona, USA.; Department of Neurology, Mayo Clinic, Phoenix, AZ, USA.
Pokaż więcej
Źródło:
Cephalalgia : an international journal of headache [Cephalalgia] 2021 May; Vol. 41 (6), pp. 749-759. Date of Electronic Publication: 2021 Feb 20.
Typ publikacji:
Journal Article
MeSH Terms:
Brain Concussion*
Neuralgia*
Calcitonin Gene-Related Peptide/*pharmacology
Diffuse Noxious Inhibitory Control/*drug effects
Post-Traumatic Headache/*drug therapy
Animals ; Antibodies, Monoclonal ; Calcitonin ; Capsaicin/pharmacology ; Chronic Pain ; Disease Models, Animal ; Hyperalgesia/etiology ; Hyperalgesia/prevention & control ; Male ; Mice ; Mice, Inbred C57BL
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknieSzczegóły
Tytuł:
A novel, injury-free rodent model of vulnerability for assessment of acute and preventive therapies reveals temporal contributions of CGRP-receptor activation in migraine-like pain.
Autorzy:
Kopruszinski CM; Department of Pharmacology, College of Medicine, University of Arizona, Tucson, AZ, USA.
Navratilova E; Department of Pharmacology, College of Medicine, University of Arizona, Tucson, AZ, USA.
Swiokla J; Department of Pharmacology, College of Medicine, University of Arizona, Tucson, AZ, USA.
Dodick DW; Department of Neurology, Mayo Clinic, Phoenix, AZ, USA.
Chessell IP; Neuroscience, BioPharmaceuticals R&D, AstraZeneca, Cambridge, UK.
Porreca F; Department of Pharmacology, College of Medicine, University of Arizona, Tucson, AZ, USA.; Department of Neurology, Mayo Clinic, Phoenix, AZ, USA.
Pokaż więcej
Źródło:
Cephalalgia : an international journal of headache [Cephalalgia] 2021 Mar; Vol. 41 (3), pp. 305-317. Date of Electronic Publication: 2020 Sep 26.
Typ publikacji:
Journal Article; Research Support, N.I.H., Extramural
MeSH Terms:
Migraine Disorders*/prevention & control
Pain*
Animals ; Calcitonin Gene-Related Peptide ; Disease Models, Animal ; Female ; Hyperalgesia/chemically induced ; Hyperalgesia/prevention & control ; Male ; Mice ; Mice, Inbred C57BL ; Narcotic Antagonists ; Propranolol ; Rats ; Rats, Sprague-Dawley ; Receptors, Calcitonin Gene-Related Peptide ; Receptors, Opioid, kappa ; Sumatriptan
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknieSzczegóły
Tytuł:
Evaluation of green light exposure on headache frequency and quality of life in migraine patients: A preliminary one-way cross-over clinical trial.
Autorzy:
Martin LF; Department of Anesthesiology, College of Medicine, University of Arizona, Tucson, AZ, USA.; Department of Pharmacology, College of Medicine, University of Arizona, Tucson, AZ, USA.
Patwardhan AM; Department of Anesthesiology, College of Medicine, University of Arizona, Tucson, AZ, USA.; Department of Pharmacology, College of Medicine, University of Arizona, Tucson, AZ, USA.; Department of Neurosurgery, College of Medicine, University of Arizona, Tucson, AZ, USA.; Comprehensive Pain and Addiction Center, University of Arizona, Tucson, AZ, USA.
Jain SV; Department of Neurology, College of Medicine, University of Arizona, Tucson, AZ, USA.
Salloum MM; Department of Anesthesiology, College of Medicine, University of Arizona, Tucson, AZ, USA.
Freeman J; Department of Anesthesiology, College of Medicine, University of Arizona, Tucson, AZ, USA.
Khanna R; Department of Anesthesiology, College of Medicine, University of Arizona, Tucson, AZ, USA.; Department of Pharmacology, College of Medicine, University of Arizona, Tucson, AZ, USA.; Comprehensive Pain and Addiction Center, University of Arizona, Tucson, AZ, USA.
Gannala P; Department of Anesthesiology, College of Medicine, University of Arizona, Tucson, AZ, USA.
Goel V; Department of Anesthesiology, University of Minnesota, Minneapolis, MN, USA.
Jones-MacFarland FN; Department of Neurology, College of Medicine, University of Arizona, Tucson, AZ, USA.
Killgore WD; Department of Psychiatry, College of Medicine, University of Arizona, Tucson, AZ, USA.
Porreca F; Department of Anesthesiology, College of Medicine, University of Arizona, Tucson, AZ, USA.; Department of Pharmacology, College of Medicine, University of Arizona, Tucson, AZ, USA.
Ibrahim MM; Department of Anesthesiology, College of Medicine, University of Arizona, Tucson, AZ, USA.; Department of Pharmacology, College of Medicine, University of Arizona, Tucson, AZ, USA.; Department of Neurosurgery, College of Medicine, University of Arizona, Tucson, AZ, USA.; Comprehensive Pain and Addiction Center, University of Arizona, Tucson, AZ, USA.
Pokaż więcej
Źródło:
Cephalalgia : an international journal of headache [Cephalalgia] 2021 Feb; Vol. 41 (2), pp. 135-147. Date of Electronic Publication: 2020 Sep 09.
Typ publikacji:
Clinical Trial; Journal Article; Research Support, N.I.H., Extramural
MeSH Terms:
Migraine Disorders*/therapy
Quality of Life*
Cross-Over Studies ; Headache ; Humans ; Light ; Pain ; Treatment Outcome
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Characterization and preclinical evaluation of a protease activated receptor 2 (PAR2) monoclonal antibody as a preventive therapy for migraine.
Autorzy:
Kopruszinski CM; Department of Pharmacology, College of Medicine, University of Arizona, Tucson, AZ, USA.
Thornton P; Neuroscience, R&D BioPharmaceuticals, AstraZeneca, Cambridge, UK.
Arnold J; ADPE, R&D BioPharmaceuticals, AstraZeneca, Cambridge, UK.
Newton P; ADPE, R&D BioPharmaceuticals, AstraZeneca, Cambridge, UK.
Lowne D; ADPE, R&D BioPharmaceuticals, AstraZeneca, Cambridge, UK.
Navratilova E; Department of Pharmacology, College of Medicine, University of Arizona, Tucson, AZ, USA.
Swiokla J; Department of Pharmacology, College of Medicine, University of Arizona, Tucson, AZ, USA.
Dodick DW; Department of Neurology, Mayo Clinic, Phoenix, AZ, USA.
Dobson C; ADPE, R&D BioPharmaceuticals, AstraZeneca, Cambridge, UK.
Gurrell I; Neuroscience, R&D BioPharmaceuticals, AstraZeneca, Cambridge, UK.
Chessell IP; Neuroscience, R&D BioPharmaceuticals, AstraZeneca, Cambridge, UK.
Porreca F; Department of Pharmacology, College of Medicine, University of Arizona, Tucson, AZ, USA.; Department of Neurology, Mayo Clinic, Phoenix, AZ, USA.
Pokaż więcej
Źródło:
Cephalalgia : an international journal of headache [Cephalalgia] 2020 Dec; Vol. 40 (14), pp. 1535-1550. Date of Electronic Publication: 2020 Nov 01.
Typ publikacji:
Journal Article
MeSH Terms:
Calcitonin Gene-Related Peptide*
Migraine Disorders*/drug therapy
Migraine Disorders*/prevention & control
Animals ; Antibodies, Monoclonal ; Female ; Hyperalgesia/prevention & control ; Mice ; Mice, Inbred C57BL ; Pain ; Peptide Hydrolases ; Rats ; Receptor, PAR-1 ; Receptor, PAR-2
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Evaluation of LY573144 (lasmiditan) in a preclinical model of medication overuse headache.
Autorzy:
Rau JC; Mayo Clinic, Scottsdale, AZ, USA.
Navratilova E; Department of Pharmacology, Arizona Health Sciences Center, University of Arizona, Tucson, AZ, USA.
Oyarzo J; Mayo Clinic, Scottsdale, AZ, USA.
Johnson KW; Eli Lilly, Indianapolis, IN, USA.
Aurora SK; Eli Lilly, Indianapolis, IN, USA.
Schwedt TJ; Mayo Clinic, Scottsdale, AZ, USA.
Dodick DW; Mayo Clinic, Scottsdale, AZ, USA.
Porreca F; Mayo Clinic, Scottsdale, AZ, USA.; Department of Pharmacology, Arizona Health Sciences Center, University of Arizona, Tucson, AZ, USA.
Pokaż więcej
Źródło:
Cephalalgia : an international journal of headache [Cephalalgia] 2020 Aug; Vol. 40 (9), pp. 903-912. Date of Electronic Publication: 2020 Jun 24.
Typ publikacji:
Journal Article
MeSH Terms:
Analgesics/*toxicity
Benzamides/*toxicity
Headache Disorders, Secondary/*chemically induced
Hyperalgesia/*chemically induced
Piperidines/*toxicity
Pyridines/*toxicity
Serotonin Receptor Agonists/*toxicity
Animals ; Central Nervous System Sensitization/drug effects ; Disease Models, Animal ; Rats ; Rats, Sprague-Dawley ; Sumatriptan/toxicity
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Ubrogepant does not induce latent sensitization in a preclinical model of medication overuse headache.
Autorzy:
Navratilova E; Department of Pharmacology, Arizona Health Sciences Center, University of Arizona, Tucson, AZ, USA.
Behravesh S; Department of Collaborative Research, Mayo Clinic, Scottsdale, AZ, USA.
Oyarzo J; Department of Collaborative Research, Mayo Clinic, Scottsdale, AZ, USA.
Dodick DW; Department of Neurology, Mayo Clinic, Scottsdale, AZ, USA.
Banerjee P; Allergan plc, Madison, NJ, USA.
Porreca F; Department of Pharmacology, Arizona Health Sciences Center, University of Arizona, Tucson, AZ, USA.; Department of Collaborative Research, Mayo Clinic, Scottsdale, AZ, USA.
Pokaż więcej
Źródło:
Cephalalgia : an international journal of headache [Cephalalgia] 2020 Aug; Vol. 40 (9), pp. 892-902. Date of Electronic Publication: 2020 Jul 02.
Typ publikacji:
Journal Article
MeSH Terms:
Headache Disorders, Secondary*
Analgesics/*pharmacology
Central Nervous System Sensitization/*drug effects
Hyperalgesia/*chemically induced
Pyridines/*pharmacology
Pyrroles/*pharmacology
Animals ; Disease Models, Animal ; Female ; Rats ; Rats, Sprague-Dawley ; Sumatriptan/pharmacology
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Cannabinoids induce latent sensitization in a preclinical model of medication overuse headache.
Autorzy:
Kopruszinski CM; Department of Pharmacology, College of Medicine, University of Arizona, Tucson, AZ, USA.
Navratilova E; Department of Pharmacology, College of Medicine, University of Arizona, Tucson, AZ, USA.
Vagnerova B; Department of Pharmacology, College of Medicine, University of Arizona, Tucson, AZ, USA.
Swiokla J; Department of Pharmacology, College of Medicine, University of Arizona, Tucson, AZ, USA.
Patwardhan A; Department of Pharmacology, College of Medicine, University of Arizona, Tucson, AZ, USA.
Dodick D; Department of Neurology, Mayo Clinic, Phoenix, AZ, USA.
Porreca F; Department of Pharmacology, College of Medicine, University of Arizona, Tucson, AZ, USA.; Department of Neurology, Mayo Clinic, Phoenix, AZ, USA.
Pokaż więcej
Źródło:
Cephalalgia : an international journal of headache [Cephalalgia] 2020 Jan; Vol. 40 (1), pp. 68-78. Date of Electronic Publication: 2019 Jul 16.
Typ publikacji:
Journal Article
MeSH Terms:
Disease Models, Animal*
Benzoxazines/*toxicity
Cannabinoid Receptor Agonists/*toxicity
Dronabinol/*toxicity
Headache Disorders, Secondary/*chemically induced
Morpholines/*toxicity
Naphthalenes/*toxicity
Pain Measurement/*drug effects
Animals ; Cannabinoids/toxicity ; Dose-Response Relationship, Drug ; Female ; Headache Disorders, Secondary/psychology ; Pain Measurement/methods ; Rats ; Rats, Sprague-Dawley
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
CGRP-dependent and independent mechanisms of acute and persistent post-traumatic headache following mild traumatic brain injury in mice.
Autorzy:
Navratilova E; Department of Pharmacology, Arizona Health Sciences Center, University of Arizona, Tucson, AZ, USA.
Rau J; Mayo Clinic, Scottsdale, AZ, USA.
Oyarzo J; Mayo Clinic, Scottsdale, AZ, USA.
Tien J; Teva Biologics, Redwood City, CA, USA.
Mackenzie K; Teva Biologics, Redwood City, CA, USA.
Stratton J; Teva Biologics, Redwood City, CA, USA.
Remeniuk B; Department of Pharmacology, Arizona Health Sciences Center, University of Arizona, Tucson, AZ, USA.
Schwedt T; Mayo Clinic, Scottsdale, AZ, USA.
Anderson T; Department of Basic Medical Sciences, University of Arizona College of Medicine, Phoenix, AZ, USA.
Dodick D; Mayo Clinic, Scottsdale, AZ, USA.
Porreca F; Department of Pharmacology, Arizona Health Sciences Center, University of Arizona, Tucson, AZ, USA.; Mayo Clinic, Scottsdale, AZ, USA.
Pokaż więcej
Źródło:
Cephalalgia : an international journal of headache [Cephalalgia] 2019 Dec; Vol. 39 (14), pp. 1762-1775. Date of Electronic Publication: 2019 Sep 24.
Typ publikacji:
Journal Article
MeSH Terms:
Brain Concussion/*chemically induced
Brain Concussion/*drug therapy
Calcitonin Gene-Related Peptide/*toxicity
Calcitonin Gene-Related Peptide Receptor Antagonists/*therapeutic use
Post-Traumatic Headache/*chemically induced
Post-Traumatic Headache/*drug therapy
Acute Disease ; Animals ; Brain Concussion/physiopathology ; Chronic Disease ; Male ; Mice ; Mice, Inbred C57BL ; Post-Traumatic Headache/physiopathology ; Vasodilator Agents/toxicity
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknieSzczegóły
Tytuł:
Sustained exposure to acute migraine medications combined with repeated noxious stimulation dysregulates descending pain modulatory circuits: Relevance to medication overuse headache.
Autorzy:
Nation KM; 1 Department of Pharmacology, University of Arizona, Tucson, AZ, USA.
Dodick DW; 2 Mayo Clinic, Scottsdale, AZ, USA.
Navratilova E; 1 Department of Pharmacology, University of Arizona, Tucson, AZ, USA.; 2 Mayo Clinic, Scottsdale, AZ, USA.
Porreca F; 1 Department of Pharmacology, University of Arizona, Tucson, AZ, USA.; 2 Mayo Clinic, Scottsdale, AZ, USA.
Pokaż więcej
Źródło:
Cephalalgia : an international journal of headache [Cephalalgia] 2019 Apr; Vol. 39 (5), pp. 617-625. Date of Electronic Publication: 2018 Oct 04.
Typ publikacji:
Journal Article
MeSH Terms:
Analgesics/*pharmacology
Headache Disorders, Secondary/*physiopathology
Hyperalgesia/*physiopathology
Migraine Disorders/*physiopathology
Analgesics, Opioid/pharmacology ; Animals ; Male ; Morphine/pharmacology ; Rats ; Rats, Sprague-Dawley ; Repetition Priming/drug effects ; Repetition Priming/physiology ; Serotonin 5-HT1 Receptor Agonists/pharmacology ; Sumatriptan/pharmacology
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
The opioid crisis and … reconsidering the use of drugs that affect body temperature.
Autorzy:
Patwardhan A; Departments of Pharmacology and Anesthesiology, College of Medicine, University of Arizona, Tucson, AZ, USA.
Porreca F; Departments of Anesthesiology and Pharmacology, College of Medicine, University of Arizona, Tucson, AZ, USA.
Schmidt WK; Catalina Pharma Inc., Davis, CA, USA.
Romanovsky AA; St. Joseph's Hospital and Medical Center, Dignity Health, Phoenix, AZ, USA.
Pokaż więcej
Źródło:
Temperature (Austin, Tex.) [Temperature (Austin)] 2018 Mar 06; Vol. 5 (1), pp. 1-3. Date of Electronic Publication: 2018 Mar 06 (Print Publication: 2018).
Typ publikacji:
Editorial
Opinia redakcyjna
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Activation of ventral tegmental area dopaminergic neurons reverses pathological allodynia resulting from nerve injury or bone cancer.
Autorzy:
Watanabe M; 1 Department of Pharmacology, Hoshi University School of Pharmacy and Pharmaceutical Sciences, Shinagawa-ku, Tokyo, Japan.
Narita M; 1 Department of Pharmacology, Hoshi University School of Pharmacy and Pharmaceutical Sciences, Shinagawa-ku, Tokyo, Japan.
Hamada Y; 1 Department of Pharmacology, Hoshi University School of Pharmacy and Pharmaceutical Sciences, Shinagawa-ku, Tokyo, Japan.
Yamashita A; 1 Department of Pharmacology, Hoshi University School of Pharmacy and Pharmaceutical Sciences, Shinagawa-ku, Tokyo, Japan.
Tamura H; 2 Life Science Tokyo Advanced Research Center (L-StaR), Hoshi University School of Pharmacy and Pharmaceutical Sciences, Shinagawa-ku, Tokyo, Japan.
Ikegami D; 1 Department of Pharmacology, Hoshi University School of Pharmacy and Pharmaceutical Sciences, Shinagawa-ku, Tokyo, Japan.; 3 Department of Pharmacology, Arizona Health Sciences Center, University of Arizona, Tucson, AZ, USA.
Kondo T; 1 Department of Pharmacology, Hoshi University School of Pharmacy and Pharmaceutical Sciences, Shinagawa-ku, Tokyo, Japan.
Shinzato T; 1 Department of Pharmacology, Hoshi University School of Pharmacy and Pharmaceutical Sciences, Shinagawa-ku, Tokyo, Japan.
Shimizu T; 4 Department of Pathophysiology, Hoshi University School of Pharmacy and Pharmaceutical Sciences, Shinagawa-ku, Tokyo, Japan.
Fukuchi Y; 4 Department of Pathophysiology, Hoshi University School of Pharmacy and Pharmaceutical Sciences, Shinagawa-ku, Tokyo, Japan.
Muto A; 4 Department of Pathophysiology, Hoshi University School of Pharmacy and Pharmaceutical Sciences, Shinagawa-ku, Tokyo, Japan.
Okano H; 2 Life Science Tokyo Advanced Research Center (L-StaR), Hoshi University School of Pharmacy and Pharmaceutical Sciences, Shinagawa-ku, Tokyo, Japan.; 5 Department of Physiology, Keio University School of Medicine, Shinjuku-ku, Tokyo, Japan.
Yamanaka A; 6 Department of Neuroscience II, Research Institute of Environmental Medicine, Nagoya University, Furo-cho, Chikusa-ku, Nagoya, Japan.
Tawfik VL; 7 Department of Anesthesiology, Perioperative and Pain Medicine, Stanford University School of Medicine, Palo Alto, CA, USA.
Kuzumaki N; 1 Department of Pharmacology, Hoshi University School of Pharmacy and Pharmaceutical Sciences, Shinagawa-ku, Tokyo, Japan.
Navratilova E; 3 Department of Pharmacology, Arizona Health Sciences Center, University of Arizona, Tucson, AZ, USA.
Porreca F; 3 Department of Pharmacology, Arizona Health Sciences Center, University of Arizona, Tucson, AZ, USA.
Narita M; 1 Department of Pharmacology, Hoshi University School of Pharmacy and Pharmaceutical Sciences, Shinagawa-ku, Tokyo, Japan.; 2 Life Science Tokyo Advanced Research Center (L-StaR), Hoshi University School of Pharmacy and Pharmaceutical Sciences, Shinagawa-ku, Tokyo, Japan.
Pokaż więcej
Źródło:
Molecular pain [Mol Pain] 2018 Jan-Dec; Vol. 14, pp. 1744806918756406. Date of Electronic Publication: 2018 Jan 22.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Bone Neoplasms/*complications
Dopaminergic Neurons/*pathology
Hyperalgesia/*etiology
Hyperalgesia/*pathology
Sciatic Nerve/*injuries
Ventral Tegmental Area/*pathology
Animals ; Bone Neoplasms/physiopathology ; Cancer Pain/etiology ; Cancer Pain/pathology ; Cancer Pain/physiopathology ; Cell Line, Tumor ; Dopaminergic Neurons/metabolism ; Hyperalgesia/physiopathology ; Ligation ; Male ; Mice, Inbred C57BL ; Neuralgia/pathology ; Nucleus Accumbens/pathology ; Nucleus Accumbens/physiopathology ; Sciatic Nerve/pathology ; Sciatic Nerve/physiopathology ; Ventral Tegmental Area/physiopathology
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknieSzczegóły
Tytuł:
Extracellular N-acetylaspartylglutamate released in the nucleus accumbens modulates the pain sensation: Analysis using a microdialysis/mass spectrometry integrated system.
Autorzy:
Watanabe M; 1 Department of Pharmacology, Hoshi University School of Pharmacy and Pharmaceutical Sciences, Tokyo, Japan.
Sugiura Y; 2 Department of Biochemistry, Keio University School of Medicine, Tokyo, Japan.
Sugiyama E; 2 Department of Biochemistry, Keio University School of Medicine, Tokyo, Japan.
Narita M; 1 Department of Pharmacology, Hoshi University School of Pharmacy and Pharmaceutical Sciences, Tokyo, Japan.
Navratilova E; 3 Department of Pharmacology, Arizona Health Sciences Center, University of Arizona, Tucson, AZ, USA.
Kondo T; 1 Department of Pharmacology, Hoshi University School of Pharmacy and Pharmaceutical Sciences, Tokyo, Japan.
Uchiyama N; 1 Department of Pharmacology, Hoshi University School of Pharmacy and Pharmaceutical Sciences, Tokyo, Japan.
Yamanaka A; 4 Department of Neuroscience II, Research Institute of Environmental Medicine, Nagoya University, Nagoya, Japan.
Kuzumaki N; 1 Department of Pharmacology, Hoshi University School of Pharmacy and Pharmaceutical Sciences, Tokyo, Japan.
Porreca F; 3 Department of Pharmacology, Arizona Health Sciences Center, University of Arizona, Tucson, AZ, USA.
Narita M; 1 Department of Pharmacology, Hoshi University School of Pharmacy and Pharmaceutical Sciences, Tokyo, Japan.; 5 Life Science Tokyo Advanced Research Center (L-StaR), Hoshi University School of Pharmacy and Pharmaceutical Sciences, Tokyo, Japan.
Pokaż więcej
Źródło:
Molecular pain [Mol Pain] 2018 Jan-Dec; Vol. 14, pp. 1744806918754934. Date of Electronic Publication: 2018 Jan 08.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Mass Spectrometry*
Microdialysis*
Sensation*
Dipeptides/*metabolism
Extracellular Space/*metabolism
Nucleus Accumbens/*metabolism
Pain/*metabolism
Analgesia ; Animals ; Behavior, Animal ; Body Fluids/metabolism ; Channelrhodopsins/metabolism ; Dopamine/metabolism ; Humans ; Male ; Mice, Inbred C57BL ; Optogenetics ; Pain/pathology ; Pain Threshold ; Sensory Receptor Cells/metabolism ; Sensory Receptor Cells/pathology ; Small Molecule Libraries/metabolism
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknieSzczegóły
Tytuł:
Anatomy and immunochemical characterization of the non-arterial peptidergic diffuse dural innervation of the rat and Rhesus monkey: Implications for functional regulation and treatment in migraine.
Autorzy:
Rice FL; 1 Integrated Tissue Dynamics LLC, Rensselaer, NY, USA.
Xie JY; 2 Department of Pharmacology, Arizona Health Sciences Center, University of Arizona, Tucson, AZ, USA.
Albrecht PJ; 1 Integrated Tissue Dynamics LLC, Rensselaer, NY, USA.
Acker E; 1 Integrated Tissue Dynamics LLC, Rensselaer, NY, USA.
Bourgeois J; 1 Integrated Tissue Dynamics LLC, Rensselaer, NY, USA.
Navratilova E; 2 Department of Pharmacology, Arizona Health Sciences Center, University of Arizona, Tucson, AZ, USA.
Dodick DW; 3 Departments of Collaborative Research and Neurology, Mayo Clinic, Scottsdale, AZ, USA.
Porreca F; 2 Department of Pharmacology, Arizona Health Sciences Center, University of Arizona, Tucson, AZ, USA.; 3 Departments of Collaborative Research and Neurology, Mayo Clinic, Scottsdale, AZ, USA.
Pokaż więcej
Źródło:
Cephalalgia : an international journal of headache [Cephalalgia] 2017 Dec; Vol. 37 (14), pp. 1350-1372. Date of Electronic Publication: 2016 Nov 16.
Typ publikacji:
Journal Article
MeSH Terms:
Dura Mater/*metabolism
Dura Mater/*pathology
Migraine Disorders/*metabolism
Migraine Disorders/*pathology
Nerve Fibers, Unmyelinated/*metabolism
Nerve Fibers, Unmyelinated/*pathology
Animals ; Calcitonin Gene-Related Peptide/analysis ; Calcitonin Gene-Related Peptide/metabolism ; Capillaries/chemistry ; Capillaries/metabolism ; Capillaries/pathology ; Dura Mater/chemistry ; Macaca mulatta ; Male ; Migraine Disorders/therapy ; Nerve Fibers, Unmyelinated/chemistry ; Rats ; Rats, Sprague-Dawley ; Receptor Activity-Modifying Protein 1/analysis ; Receptor Activity-Modifying Protein 1/metabolism ; Receptors, Adrenergic, alpha-1/metabolism ; Receptors, Calcitonin Gene-Related Peptide/analysis ; Receptors, Calcitonin Gene-Related Peptide/metabolism ; Species Specificity ; TRPV Cation Channels/analysis ; TRPV Cation Channels/metabolism ; Treatment Outcome
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Wyświetlanie 1-20 z 53

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies